BVNRY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 23:20):

Stats
今日成交量	892.00
平均成交量	5 243.00
市值	1.65B
EPS	$0 ( 2024-03-07 )
下一个收益日期	( $0 ) 2024-05-14
Last Dividend	$0.593 ( 2020-03-27 )
Next Dividend	$0 ( N/A )
P/E	7.66
ATR14	$0 (0.00%)

Bavarian Nordic A/S 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Bavarian Nordic A/S 财务报表

Annual	2023
营收:	$7.06B
毛利润:	$4.52B (64.07 %)
EPS:	$19.23

FY	2023
营收:	$7.06B
毛利润:	$4.52B (64.07 %)
EPS:	$19.23

FY	2023
营收:	$0
毛利润:	$0 (0.00 %)
EPS:	$0

FY	2022
营收:	$3.15B
毛利润:	$1.70B (53.99 %)
EPS:	$-4.93

Financial Reports:

No articles found.

Bavarian Nordic A/S Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Bavarian Nordic A/S Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.34 - Potential for dividend initiation, but uncertain (13.19%)

Information

First Dividend	$0.593	2020-03-27
Last Dividend	$0.593	2020-03-27
Next Dividend	$0	N/A
Payout Date	2020-04-06
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.593	--
Avg. Dividend % Per Year	0.00%	--
Score	2.27	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.34
Div. Directional Score	7.53	--

Next Divdend (Est)
(2024-04-27)

$0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

2.27

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
NLCP	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
CTUY	Ex Dividend Junior	2023-05-24	Annually	0.00%
THNPF	Ex Dividend Knight	2023-05-22	Annually	0.00%
IDCBY	Ex Dividend Junior	2023-07-06	Annually	0.00%
BCNAY	Ex Dividend Knight	2023-05-12	Annually	0.00%
PLDGP	Ex Dividend Knight	2023-09-15	Quarterly	0.00%
EDPFY	Ex Dividend Junior	2023-05-01	Annually	0.00%
UEPEM	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
KBCSY	Ex Dividend Junior	2023-05-09	Annually	0.00%
BYDDF	Ex Dividend Junior	2023-06-13	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.209	1.500	5.82	8.74	[0 - 0.5]
returnOnAssetsTTM	0.103	1.200	6.57	7.89	[0 - 0.3]
returnOnEquityTTM	0.153	1.500	9.41	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.938	0.800	5.31	4.25	[1 - 3]
quickRatioTTM	1.342	0.800	6.81	5.45	[0.8 - 2.5]
cashRatioTTM	0.530	1.500	8.17	10.00	[0.2 - 2]
debtRatioTTM	0.00430	-1.500	9.93	-10.00	[0 - 0.6]
interestCoverageTTM	25.16	1.000	1.793	1.793	[3 - 30]
operatingCashFlowPerShareTTM	14.59	2.00	5.14	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.849	2.00	9.08	10.00	[0 - 20]
debtEquityRatioTTM	0.00597	-1.500	9.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.652	1.000	2.47	2.47	[0.2 - 0.8]
operatingProfitMarginTTM	0.215	1.000	7.70	7.70	[0.1 - 0.6]
cashFlowToDebtRatioTTM	18.15	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.492	0.800	-0.0521	-0.0416	[0.5 - 2]
Total Score				10.72

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	2.55	1.000	9.84	0	[1 - 100]
returnOnEquityTTM	0.153	2.50	9.62	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.849	2.00	9.38	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	14.59	2.00	5.14	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00228	1.500	-3.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.54	0	[0.1 - 0.5]
Total Score				4.34

Bavarian Nordic A/S

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name. It is also developing MVA-BN (freeze-dried) that has completed Phase III clinical trials for the treatment of smallpox; MVA-BN RSV, which is in Phase III clinical trials for the treatment of respiratory syncytial virus; ABNCoV2 that has completed Phase II clinical trial for the treatment of SARS-CoV-2; and TAEK-VAC, which is in Phase I/II clinical trial for treatment of advanced HER2 and brachyury-expressing cancers. It has license and collaboration agreement with AdaptVac; and license agreements with National Cancer Institute and Public Health Service. The company operates in the United States, Belgium, Germany, the Netherlands, Sweden, Switzerland, Austria, the United Kingdom, Japan, and internationally. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.